Post-traumatic stress disorder (PTSD) affects roughly 7 million people in the United States alone. It is associated with a variety of comorbid conditions, including depression, anxiety, and increased risk of heart attack. Developing effective new therapies to combat it is thus an essential activity.
In a study published in the European Journal of Psychotraumatology, six couples participated in accelerated Cognitive-Behavioral Conjoint Therapy (CBCT), two session of which occurred while under the influence of 3,4-methylenedioxymethamphetamine, more commonly known as MDMA. In each of the six couples, one partner had been diagnosed with PTSD.
Conjoint CBT has been shown to be particularly effective in the treatment of PTSD, focusing on “the relationship between the participants as the treatment target,” such that couples develop their skills “as a dyad, both in terms of communication as well as reduction of avoidance and challenging of beliefs.”
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers